Skip to main content
Caplight Logo









CardioStory

CardioStory

Private
Palo Alto, CaliforniaHealthcare & Life Scienceshttps://www.cardiostory.com/

Last Round

Accelerator

Mar 1, 2023

Momentum

Top 50%

of companies Caplight tracks

Company Overview

CardioStory operates in Healthcare & Life Sciences and is based in Palo Alto, California. Its latest recorded funding round was an Accelerator round in March 2023.

CardioStory is a medical device company that develops non-invasive filling pressure monitoring platforms for heart failure patients using proprietary fiber-optic sensor technology.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Health IoT, Medical AI, Sensors, Telemedicine

Business Model

B2B

Customer Profile

Hardware Sales, Hardware + Subscription

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

CardioStory Comparables

Compare CardioStory with similar companies based on industry and business-model similarity.

CardioStory comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Acorai
90%
Cardiosense
87%
Ventric Health
80%
Book a demo to see all comparables

For institutional investors. Book with your work email.

CardioStory Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AcceleratorMar 1, 2023
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 27, 2026

    Monthly visitors increased 146% MoM.

  • May 1, 2025

    Monthly visitors grew 1798% MoM, from 47 to 892.

Book a demo to see all signals

For institutional investors. Book with your work email.

CardioStory Filings

Explore SEC and related filing metadata, where available.

CardioStory filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about CardioStory's valuation, stock price, and market status.

Is CardioStory a public or private company?

CardioStory is a private company.

What is the current stock price of CardioStory?

CardioStory is a private company, so its shares have no public market price. Caplight tracks CardioStory's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is CardioStory worth (valuation)?

Valuation information for CardioStory is not publicly available.

Can I buy CardioStory stock?

CardioStory shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was CardioStory's last funding round?

CardioStory's most recent funding round was Accelerator on March 1, 2023.

Who are the main investors in CardioStory?

Investor information for CardioStory is not publicly disclosed.

Will CardioStory IPO soon?

No public IPO plans have been announced for CardioStory.

How can I track CardioStory secondary market activity?

Caplight tracks bids, offers, and trades in CardioStory's shares on secondary markets.

Firmographic Details

HeadquartersPalo Alto, California
Employee Range2
Year Founded2021
Last FundingMar 1, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?